Grace and Molecule.one strike multi-year AI pact to break peptide manufacturing bottlenecks
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
LANXESS Biosecurity Solutions aims to deliver “advanced disinfection and hygiene solutions to support Indian farmers in maintaining healthier and safer farm environments
The company will soon be launching a new portfolio of products in this segment
The non-dilutive financing includes three tranches
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Subscribe To Our Newsletter & Stay Updated